Drugs / CTAP201
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00792857 | Nov 2008 → Sep 2009 | chronic renal failure syndrome, secondary hyperparathyroidism of renal origin | OPKO IP Holdings II, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTAP201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00792857 ↗ |
| Route | Intravenous | “I.V. CTAP201” NCT00792857 ↗ |